Last reviewed · How we verify

NCT03460119: HFNC

High Flow Nasal Cannula in the Emergency Department

Completed Last updated 9 March 2018
What this trial tests

trial testing High Flow Nasal Cannula Oxygen in Acute Respiratory Failure in 43 participants. Completed in 31 January 2017.

Timeline
1 July 2015
Primary endpoint
31 January 2017
31 January 2017

Quick facts

Lead sponsorHospital Italiano de Buenos Aires
StatusCompleted
Study typeOBSERVATIONAL
Enrollment43
Start date1 July 2015
Primary completion31 January 2017
Estimated completion31 January 2017

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Italiano de Buenos Aires

Who can join

18 and older, any sex, with Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to describe the changes in respiratory rate, heart rate and dyspnea, before and after using HFNC in patients presenting to our emergency department with ARF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Respiratory Failure

Currently open trials in the same condition.

Other Hospital Italiano de Buenos Aires trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03460119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing